Trifluridine indications and usage: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Trifluridine}} {{CMG}} ==Indications And Usage== VIROPTIC Ophthalmic Solution, 1% (trifluridine ophthalmic solution) is indicated for the treatment of primary ker..." |
|||
| Line 4: | Line 4: | ||
==Indications And Usage== | ==Indications And Usage== | ||
VIROPTIC Ophthalmic Solution, 1% (trifluridine ophthalmic solution) is indicated for the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | publisher = |date = | accessdate = }}</ref> | VIROPTIC Ophthalmic Solution, 1% (trifluridine ophthalmic solution) is indicated for the treatment of primary [[keratoconjunctivitis]] and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf | publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Revision as of 15:56, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications And Usage
VIROPTIC Ophthalmic Solution, 1% (trifluridine ophthalmic solution) is indicated for the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022211s000_sumr.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.